| Breakdown | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.44B | 7.83B | 9.96B | 10.03B | 7.65B |
| Gross Profit | 1.89B | 1.77B | 2.63B | 2.50B | 2.13B |
| EBITDA | 1.03B | 976.60M | 1.74B | 1.61B | 1.39B |
| Net Income | 291.60M | -213.10M | 743.40M | 863.90M | 793.90M |
Balance Sheet | |||||
| Total Assets | 6.32B | 6.29B | 6.78B | 6.46B | 5.03B |
| Cash, Cash Equivalents and Short-Term Investments | 427.10M | 180.70M | 491.80M | 202.30M | 265.80M |
| Total Debt | 2.68B | 3.13B | 2.95B | 3.02B | 2.19B |
| Total Liabilities | 5.71B | 6.05B | 5.96B | 5.92B | 5.16B |
| Stockholders Equity | 604.10M | 241.30M | 808.90M | 534.90M | -135.60M |
Cash Flow | |||||
| Free Cash Flow | 738.30M | 165.70M | 942.10M | -52.20M | 87.90M |
| Operating Cash Flow | 1.04B | 562.30M | 1.49B | 548.80M | 716.80M |
| Investing Cash Flow | -318.40M | -425.50M | -574.90M | -853.40M | -687.70M |
| Financing Cash Flow | -486.00M | -375.30M | -629.20M | 291.00M | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | C$15.10B | 18.88 | 14.55% | 1.44% | 7.12% | 17.15% | |
70 Outperform | C$5.12B | 8.51 | 9.92% | 1.32% | -5.33% | -57.58% | |
66 Neutral | C$21.66B | 17.79 | 6.73% | 3.69% | 0.66% | -0.61% | |
63 Neutral | C$672.57M | 7.04 | 7.13% | 1.93% | -7.25% | -143.07% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | C$9.95B | 16.32 | 8.99% | 4.10% | -0.13% | 13.73% | |
53 Neutral | C$7.12B | 25.78 | 54.95% | 0.86% | -5.14% | -87.15% |